A detailed history of Group One Trading, L.P. transactions in Legend Biotech Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 28,215 shares of LEGN stock, worth $1.41 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
28,215
Holding current value
$1.41 Million
% of portfolio
0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $1.11 Million - $1.61 Million
28,215 New
28,215 $1.25 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $146,560 - $178,534
2,560 New
2,560 $154,000
Q4 2022

Feb 09, 2023

BUY
$38.8 - $55.46 $428,002 - $611,779
11,031 Added 120.23%
20,206 $1.01 Million
Q3 2022

Nov 09, 2022

BUY
$38.15 - $57.1 $347,470 - $520,066
9,108 Added 13594.03%
9,175 $374,000
Q2 2022

Aug 11, 2022

SELL
$33.54 - $55.0 $130,470 - $213,950
-3,890 Reduced 98.31%
67 $4,000
Q1 2022

May 12, 2022

BUY
$31.02 - $48.18 $122,746 - $190,648
3,957 New
3,957 $144,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $8.36B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.